Journals / Akdeniz Tıp Dergisi / 2015 / Cilt: 1 - Sayı: 2

Transplantations which might Shed Light on Organ Rejections: Composite Tissue Transplantations

Organ Redlerine Işık Tutabilecek Nakiller: Kompozit Doku Nakilleri

Pages
77–84
Publication Date
2015-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The scientifi c community might make signifi cant progress in the early diagnosis and prevention of solid organ rejections data from future studies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transplantation is used as a cure for the end-stage renal and liver failure that may be fatal.
📊
Key Findings & Data:Extensive research has been conducted on this subject as organ rejections are a major problem of transplantation.The number of composite tissue transplants, which are performed to improve the patient’s quality of life, has increased during the last decade.
💡
Conclusion & Impact:The scientifi c community might make signifi cant progress in the early diagnosis and prevention of solid organ rejections data from future studies
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Rejeksiyon · Kompozit · Doku nakli

Abstract

Transplantation is used as a cure for the end-stage renal and liver failure that may be fatal. Although transplantation is an option for the patient to cling to life, there is a risk of rejection of the transplanted organ. Extensive research has been conducted on this subject as organ rejections are a major problem of transplantation.The number of composite tissue transplants, which are performed to improve the patient’s quality of life, has increased during the last decade. The frequency of chronic rejection in composite tissue transplantation with this method has been observed to be less than that of solid organ transplantation. A lower frequency of chronic rejection is intriguing given the fact that more immunogenic tissues are transplanted in composite tissue transplantation. The elucidation of molecular and immunological mechanisms underlying this “rare rejection” phenomenon is of utmost importance. The scientifi c community might make signifi cant progress in the early diagnosis and prevention of solid organ rejections data from future studies

Özet

Son dönem böbrek ve karaciğer yetmezliği gibi ölümle sonuçlanabilecek hastalıkların kesin tedavisi olarak organ nakli Transplantasyon uygulanmaktadır. Organ nakilleri her ne kadar hastayı yaşama bağlayan bir yöntem olsa da; nakledilen organların reddedilme riski mevcuttur. Organ Rejeksiyonlarının organ nakillerinin önemli bir dezavantajı olmasından dolayı üzerinde yapılan araştırmaların sayısı fazladır.Son on yılda hastanın yaşam kalitesini artırmak için uygulanan kompozit doku nakillerinin sayısı artmıştır. Yapılan nakil sayılarının artması sonucu, kompozit doku nakillerinde gelişen kronik rejeksiyon sıklığının solid organ naklindekinden daha az olduğu görülmüştür. Daha immünolojik özellikteki dokuların nakledilmesine rağmen kronik rejeksiyon görülme sıklığının az olması merak uyandırıcıdır. Bu seyrek görülen rejeksiyonların altında yatan moleküler ve immünolojik nedenlerin aydınlatılması büyük önem taşımaktadır. Elde edilecek bilgiler doğrultusunda solid organ nakillerinde de oluşacak rejeksiyonların erken tanısı ve de önlenmesinde bilim camiası önemli bir ilerleme gösterecektir

🔖

Cite This Article

ERTOSUN, M. G., ÖZKAN, Ö., ÖZKAN, Ö. (2015). Transplantations which might Shed Light on Organ Rejections: Composite Tissue Transplantations. Akdeniz Tıp Dergisi, Cilt: 1 - Sayı: 2, 77–84. https://ajindex.com/articles/725718

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Josien R, Pannetier C, Douillard P, Cantarovich D, Menoret S, Bugeon L, Kourilsky P, Soulillou JP, Cuturi MC. Graft-infi ltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specifi c transfusion- induced tolerance in adult rats. Transplantation 1995; 60: 1131-9.
  2. Horak I, Lohler J, Ma A. Smith KA. Interleukin-2 defi cient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 1995; 148:35-44.
  3. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas- mediated T cell apoptosis. Immunity 1998; 8: 615-23.
  4. Irmler M, Thome M, Hahne M, Schneider P, Hofmann, K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-5. Li X. The common gammac-cytokines and transplantation tolerance. Cell Mol Immunol 2004; 1:167-72.
  5. McLaughlin PJ, Aikawa A, Davies HM, Ward RG, Bakran A, Sells RA, Johnson PM. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991; 51:1225-9.
  6. Deng MC, Plenz G, Labarrere C, Marboe C, Baba HA, Erre M, Itescu, S. The role of IL6 cytokines in acute cardiac allograft rejection. Transpl Immunol 2002; 9:115- 20. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE, Geehan CS, Luster AD, Sayegh MH, Briscoe DM. Proinfl ammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003; 112, 1655-65.
  7. Luscinskas FW, Cybulsky MI, Kiely JM, Peckins CS, Davis VM, Gimbrone MA Jr. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 1991; 146: 1617-25.
  8. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodefi ciency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993; 90: 3725-9.
  9. Chang CH, Furue M, Tamaki K. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol 1994; 24: 2889-95.
  10. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, Najafi an N, Yagita H, Azuma M, T